JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online May 15, 2007
J Nucl Med 2007, doi:10.2967/jnumed.106.039396
© 2007 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.106.039396v1
48/6/873    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brighton, T.
Right arrow Articles by Butler, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brighton, T.
Right arrow Articles by Butler, S. P.


Aging of Acute Deep Vein Thrombosis Measured by Radiolabeled 99mTc-rt-PA

Timothy Brighton 1, Julia Janssen 2, and S. Patrick Butler 2*

1 Department of Haematology, St. George Hospital, Sydney, New South Wales, Australia
2 Department of Nuclear Medicine, St. George Hospital, Sydney, New South Wales, Australia

* To whom correspondence should be addressed. E-mail: sp.butler{at}unsw.edu.au.


   Abstract

In previous studies, 99mTc-recombinant tissue plasminogen activator (rt-PA) imaging has had a high sensitivity and specificity for the detection of deep vein thrombosis (DVT). In this technique, the plasminogen activation site of rt-PA undergoes inactivation but fibrin binding is retained. Uptake of 99mTc-rt-PA into DVT relies on binding of C-terminal lysine residues on fibrin. It is postulated that as the thrombus ages, fewer fibrin sites are available for 99mTc-rt-PA and that there should be a progressive decrease in 99mTc-rt-PA uptake in old thrombi as compared with fresh thrombi. The ability to differentiate fresh from old thrombus would have significant clinical implications in the objective diagnosis of recurrent DVT. Our aim was to examine the relative uptake of 99mTc-rt-PA in acute DVT over the first 30 d after diagnosis. Methods: Seventy-four patients with acute symptomatic DVT were entered into the study. Patients underwent ultrasound and 99mTc-rt-PA imaging on days 1, 7, and 30. Results: Residual thrombus was detected by ultrasonography in 46 (84%) of 55 patients on day 7 and in 29 (66%) of 44 patients on day 30. Of the persisting thrombi on day 7, 72% (33/46) showed 99mTc-rt-PA uptake. Of the persisting thrombi on day 30, 0% (0/29) showed 99mTc-rt-PA uptake. Conclusion: Uptake of 99mTc-rt-PA into DVT was absent 30 d after diagnosis. This finding suggests that this imaging technique can distinguish fresh from old thrombus.

Key Words: hematology, respiratory, vascular, imaging, recombinant tissue plasminogen activator, recurrent DVT







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.